- Reuters•1 hour ago
Biogen Inc on Wednesday reported better-than-expected third quarter profit, driven by higher sales of its lead multiple sclerosis drug and lower costs, and its shares rose more than 4 percent. However, ...
- Zacks•2 hours ago
With third quarter earnings season off to a start, investor focus remains on the performance of biotech stocks like Amgen (AMGN) and Celgene (CELG) which will be reporting results this week.
- Zacks•3 hours ago
What's in store for drug stocks Bristol-Myers, Amgen, Celgene, Alexion and Seattle Genetics when they report Q3 results on Oct 27?
Amgen Inc. (AMGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||159.71 x 200|
|Ask||159.75 x 200|
|Day's Range||158.03 - 160.05|
|52wk Range||139.02 - 176.85|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||16.32|
|Avg Vol (3m)||2,801,016|
|Dividend & Yield||4.00 (2.52%)|